The role of mTOR in bladder cancer

Cancer Biol Ther. 2009 Dec;8(24):2348-50. doi: 10.4161/cbt.8.24.10296. Epub 2009 Dec 9.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Everolimus
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Models, Biological
  • Neoplasm Metastasis
  • Phosphorylation
  • Protein Serine-Threonine Kinases / metabolism*
  • Sirolimus / analogs & derivatives
  • Sirolimus / therapeutic use
  • TOR Serine-Threonine Kinases
  • Urinary Bladder Neoplasms / pathology*

Substances

  • Antineoplastic Agents
  • Intracellular Signaling Peptides and Proteins
  • Everolimus
  • MTOR protein, human
  • Protein Serine-Threonine Kinases
  • TOR Serine-Threonine Kinases
  • Sirolimus